Location History:
- Research Triangle Park, NC (US) (2003 - 2009)
- Durham, NC (US) (1992 - 2014)
Company Filing History:
6 out of 349 
2 out of 3,684 
2 out of 836 
Years Active: 1992-2014
Title: The Remarkable Innovations of F Ivy Carroll: Pioneering Treatments for Drug Dependence
Introduction
F Ivy Carroll, a prominent inventor based in Durham, NC, has made significant contributions to the field of pharmaceutical sciences through her innovative research and inventions. With a portfolio of 10 patents, Carroll focuses on developing compounds that target drug dependence and related conditions, showcasing her commitment to improving public health.
Latest Patents
One of Carroll's latest patents, titled "Hydroxybupropion analogues for treating drug dependence," presents a revolutionary approach to treating conditions such as drug dependency, depression, and obesity. This invention involves hydroxybupropion analogues that inhibit the reuptake of monoamines and serve as antagonists at nicotinic acetylcholine receptors. These compounds are designed to selectively bind to various monoamine transporters, including those for dopamine, norepinephrine, and serotonin, offering potential new avenues for treatment.
Additionally, her patent on "Hapten compounds and compositions and uses thereof" describes hapten compounds that incorporate either (+)methamphetamine or (+)amphetamine conjugated to a linker. This innovative approach aims to elicit an immune response to these substances, potentially providing a breakthrough in addressing issues related to addiction.
Career Highlights
Throughout her career, F Ivy Carroll has been associated with notable organizations such as the Research Triangle Institute and Bristol-Myers Squibb Company. Her work at these institutions has allowed her to develop and refine her inventions, greatly contributing to the advancement of therapeutic strategies in addressing substance abuse and dependence.
Collaborations
Collaboration has been a key aspect of Carroll's work. She has worked alongside esteemed colleagues, including S Wayne Mascarella and James Barnwell Thomas, creating a collaborative environment that fosters innovation and the exchange of ideas. These partnerships have enhanced the impact of her inventions, leading to breakthroughs in the field of pharmacology.
Conclusion
F Ivy Carroll's commitment to innovation in the pharmaceutical industry is evident in her numerous patents and collaborative efforts. Her groundbreaking work on compounds for treating drug dependence and related conditions not only demonstrates her expertise but also highlights her significant role in advancing medical science. As the field of pharmaceuticals continues to evolve, Carroll's innovations hold the potential to inspire future researchers and drive new developments in treatment methodologies.